Trials / Recruiting
RecruitingNCT03097185
Analysis of Graft Function Following Autologous Islet Transplantation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Baylor Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Analyze inflammatory markers and islet graft function through blood samples collected from subjects with chronic pancreatitis who undergo total pancreatectomy with auto islet transplantation.
Detailed description
A total of 100 subjects will be enrolled in this study; 85 subjects will be enrolled from patients who are scheduled for TP-AIT and 15 subjects will be for TP alone at Baylor University Medical Center at Dallas or Baylor All Saints Medical Center at Fort Worth. The patients who are enrolled in a clinical study, named 'A phase 2/3, multicenter, randomized, double-blind, placebo-controlled, parallel assignment study to assess the efficacy and safety of reparixin in pancreatic islet auto-transplantation (REP0112, IND# 117390)', can be enrolled in this study.
Conditions
Timeline
- Start date
- 2010-06-03
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2017-03-31
- Last updated
- 2025-12-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03097185. Inclusion in this directory is not an endorsement.